Manufacturer record
Applied Communication & Controls: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Applied Communication & Controls (Uttarakhand) were declared Not of Standard Quality between July 2022 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: CAS2504, Clopidogrel & Aspirin Tablets IP (exp Nov 2027). RDTL, Ernakulam (state lab) found it not of standard quality: The Sample does not conform to IP standards with respect to the test Dissolution. For Aspirin, Related Substances for Aspirin and Assay of. Listed in the September 2026 alert.
Records by type
4 records linked to Applied Communication & Controls in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Clopidogrel & Aspirin Tablets IP | Batch CAS2504Mfg Dec 2025 · Exp Nov 2027 | The Sample does not conform to IP standards with respect to the test Dissolution. For Aspirin, Related Substances for Aspirin and Assay of Aspirin.Assay | RDTL , ErnakulamState lab | Sep 2026 |
| Levetiracetam Tablets IP 500 mg | Batch LTH2505Mfg Sep 2025 · Exp Aug 2027 | The sample does not conform to claim as per IP 2022 in respect to The Test of Dissolution.Dissolution | RDTL, ChandigarhCDSCO lab | Dec 2025 |
| Pantoprazole Sodium Tablets IP 40mg. | Batch POF-01Mfg Oct 2021 · Exp Sep 2023 | AssayAssay | RDTL GuwahatiState lab | Aug 2022 |
| Rabeprazole Sodium Tablets IP (Rabcia 20) | Batch RIA-01Mfg Jan 2021 · Exp Dec 2022 | AssayAssay | RDTL GuwahatiState lab | Jul 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.